D. Recine

CT and PET lung image registration and fusion in radiotherapy treatment planning using the chamfer-matching method.

J. Chu, J. Cai, D. Recine, 1999, International journal of radiation oncology, biology, physics.

Should multicentric disease be an absolute contraindication to the use of breast-conserving therapy?

M. Cobleigh, D. Recine, W. Hartsell, 1994, International journal of radiation oncology, biology, physics.

Combined modality therapy for locally advanced non‐small cell lung carcinoma

K. Rowland, S. Taylor, C. Kittle, 1990, Cancer.

Integration of surgery in multimodality therapy for esophageal cancer.

S. Taylor, D. Recine, W. Hartsell, 1997, American journal of clinical oncology.

Long-term results of curative irradiation in pathologically staged IA and IIA Hodgkin disease.

D. Recine, W. Hartsell, K. Griem, 1993, Radiology.

Postoperative bronchopulmonary complications in stage III lung cancer patients treated with preoperative paclitaxel-containing chemotherapy and concurrent radiation.

D. Recine, M. Sharma, P. Bonomi, 1997, Seminars in oncology.

Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.

D. Recine, P. Bonomi, L. Faber, 1995, Seminars in oncology.

What is the significance of a lobular carcinoma in situ (LCIS) component in women treated with breast conserving therapy (BCT) for early stage breast cancer

D. Recine, W. Hartsell, T. Witt, 1993 .

387 Pulmonary complications following preoperative radiation therapy and simultaneous taxol containing chemotherapy in stage III non-small cell lung cancer (NSCLC)

W. Warren, D. Recine, M. Sharma, 1997 .